Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Mereo BioPharma shifts focus to rare diseases with setrusumab showing strong results for Osteogenesis Imperfecta. Learn more on MREO stock here.

Polypharmacy was associated with a greater risk of mortality and hospitalizations at one and five years. Evidence Rating ...

Regular yogurt intake may lower the risk of Bifidobacterium-positive colorectal cancer, particularly in the proximal colon, ...

In 2019, there were 94 million cases of benign prostatic hyperplasia (BPH) worldwide. Our systematic review evaluated the effectiveness of Urtica dioica (Stinging Nettle) as a treatment of benign ...

CHENGDU, China I 8, 2025 I Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has ...

Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

Broccoli sprout extract (BSE) modestly lowered fasting blood glucose in prediabetes, but its effectiveness depended on gut ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...